Piroxicam nanoparticles for ocular delivery: Physicochemical characterization and implementation in endotoxin-induced uveitis

Piroxicam nanoparticles for ocular delivery: Physicochemical characterization and implementation in endotoxin-induced uveitis


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: خسرو ادیب کیا , محمد رضا سیاهی شادباد , علی نخودچی , علیرضا جوادزاده , محمد برزگر جلالی , ژاله برار , یداله امیدی

کلمات کلیدی: Endotoxin-induced uveitis, EudragitwRS100, nanomedicines, nanotechnology, piroxicam, ocular delivery systems

نشریه: 17392 , 5 , 15 , 2008

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله یداله امیدی
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات ریز فناوری دارویی
کد مقاله 74164
عنوان فارسی مقاله Piroxicam nanoparticles for ocular delivery: Physicochemical characterization and implementation in endotoxin-induced uveitis
عنوان لاتین مقاله Piroxicam nanoparticles for ocular delivery: Physicochemical characterization and implementation in endotoxin-induced uveitis
ناشر 7
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ خیر
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح دو – PubMed
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

To investigate the anti-inflammatory impacts of piroxicam nanosuspension, in the current investigation, piroxicam:EudragitwRS100 nanoformulations were used to control inflammatory symptoms in the rabbits with endotoxin-induced uveitis (EIU). The nanoparticles of piroxicam:EudragitwRS100 was formulated using the solvent evaporation/extraction technique. The morphological and physicochemical characteristics of nanoparticles were studied using particle size analysis, X-ray crystallography, differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FT-IR) and scanning electron microscopy (SEM). Drug release profiles were examined by fitting the data to the most common kinetic models. Selected nanosuspensions were used to assess the anti-inflammatory impacts of piroxicam nanoparticles in the rabbits with EIU. The major symptoms of EIU (i.e. inflammation and leukocytes numbers in the aqueous humor) were examined. All the prepared piroxicam formulations using EudragitwRS100 resulted in a nano-range size particles and displayed spherical smooth morphology with positively charged surface, however, the formulated particles of drug alone using same methodology failed to manifest such characteristics. The EudragitwRS100 containing nanoparticles displayed lower crystallinity than piroxicam with no chemical interactions between the drug and polymer molecules. Kinetically, the release profiles of piroxicam from nanoparticles appeared to fit best with the Weibull model and diffusion was the superior phenomenon. The in vivo examinations revealed that the inflammation can be inhibited by the drug:polymer nanosuspension more significantly than the microsuspension of drug alone in the rabbits with EIU. Upon these findings, we propose that the piroxicam:EudragitwRS100 nanosuspensions may beconsidered as an improved ocular delivery system for locally inhibition of inflammation.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
خسرو ادیب کیااول
محمد رضا سیاهی شادباددوم
علی نخودچیسوم
علیرضا جوادزادهچهارم
محمد برزگر جلالیپنجم
ژاله برارششم
یداله امیدیهشتم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
Piroxicam nanoparticles for ocular delivery.pdf1399/07/27416540دانلود